Article Details
Retrieved on: 2023-09-11 15:00:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Bill Sibold has led Sanofi's specialty care business unit for the past six years. He replaces Paul Friedman as head of the NASH drug developer.
Article found on: www.biopharmadive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here